Clinical Trial Update: Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy and safety of hydrocodone bitartrate extended-release tablets for moderate to severe chronic low back pain; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• Hydrocodone Bitartrate Extended-Release Tablets (hydrocodone bitartrate)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Low Back Pain | Phase 3 | Status: COMPLETED | Results posted: 2017-04-05